</head> <body class="production CliniciansBrief">
CB Partner Webinar {{webinarsregistrationpage::webinar_title}} true {{webinarsregistrationpage::race_approved_pending}} 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Zomedica {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

Hyperthyroidism is the most common endocrinopathy in aged cats. Nonthyroidal illness and early stages of disease can make the diagnosis difficult. Treatment of hyperthyroidism can result in hypothyroidism in many cats and is associated with the development of azotemia and shortened life expectancy. Diagnosis of hypothyroidism in cats can also be confounded by subclinical and concurrent disease. In these scenarios, simultaneous measurement of total thyroxine, free thyroxine, and thyroid-stimulating hormone (TSH) are necessary to achieve diagnosis. This webinar will discuss use and interpretation of serum thyroid hormones in various clinical scenarios that create a diagnostic challenge.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} Review the pathogenesis of feline thyroid disease, including the role of total T4, free T4, and thyroid-stimulating hormone (TSH) Why avoiding iatrogenic hypothyroidism in cats is important, even in the absence of clinical signs  How to incorporate serum hormone concentrations with clinical presentation and other diagnostic results to more accurately diagnose and manage thyroid disease in cats {{webinarsregistrationpage::what_youll_learn_bullet_4}} {{webinarsregistrationpage::what_youll_learn_bullet_5}} {{webinarsregistrationpage::what_youll_learn_bullet_6}} Company Description

Zomedica (NYSE American: ZOM) is a veterinary health company dedicated to providing clinical veterinarians with the innovative diagnostics and medical devices they need to better serve the dogs and cats in their care. The company’s mission is to advance animal health and practitioner success by focusing on the development of products and services that allow veterinarians to increase productivity and grow revenue while fostering positive health outcomes. Based in Ann Arbor, MI, the company recently launched its inaugural product, TRUFORMA®, an in-clinic biosensor platform of highly sensitive, species-specific assays offering lab quality results for the accurate diagnosis of thyroid and adrenal disorders. For more information, visit www.zomedica.com.

In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.

Hyperthyroidism is the most common endocrinopathy in aged cats. Nonthyroidal illness and early stages of disease can make the diagnosis difficult. Treatment of hyperthyroidism can result in hypothyroidism in many cats and is associated with the development of azotemia and shortened life expectancy. Diagnosis of hypothyroidism in cats can also be confounded by subclinical and concurrent disease. In these scenarios, simultaneous measurement of total thyroxine, free thyroxine, and thyroid-stimulating hormone (TSH) are necessary to achieve diagnosis. This webinar will discuss use and interpretation of serum thyroid hormones in various clinical scenarios that create a diagnostic challenge.

What You'll Learn

Company Description

Zomedica (NYSE American: ZOM) is a veterinary health company dedicated to providing clinical veterinarians with the innovative diagnostics and medical devices they need to better serve the dogs and cats in their care. The company’s mission is to advance animal health and practitioner success by focusing on the development of products and services that allow veterinarians to increase productivity and grow revenue while fostering positive health outcomes. Based in Ann Arbor, MI, the company recently launched its inaugural product, TRUFORMA®, an in-clinic biosensor platform of highly sensitive, species-specific assays offering lab quality results for the accurate diagnosis of thyroid and adrenal disorders. For more information, visit www.zomedica.com.

Hyperthyroidism is the most common endocrinopathy in aged cats. Nonthyroidal illness and early stages of disease can make the diagnosis difficult. Treatment of hyperthyroidism can result in hypothyroidism in many cats and is associated with the development of azotemia and shortened life expectancy. Diagnosis of hypothyroidism in cats can also be confounded by subclinical and concurrent disease. In these scenarios, simultaneous measurement of total thyroxine, free thyroxine, and thyroid-stimulating hormone (TSH) are necessary to achieve diagnosis. This webinar will discuss use and interpretation of serum thyroid hormones in various clinical scenarios that create a diagnostic challenge.

What You'll Learn

Company Description

Zomedica (NYSE American: ZOM) is a veterinary health company dedicated to providing clinical veterinarians with the innovative diagnostics and medical devices they need to better serve the dogs and cats in their care. The company’s mission is to advance animal health and practitioner success by focusing on the development of products and services that allow veterinarians to increase productivity and grow revenue while fostering positive health outcomes. Based in Ann Arbor, MI, the company recently launched its inaugural product, TRUFORMA®, an in-clinic biosensor platform of highly sensitive, species-specific assays offering lab quality results for the accurate diagnosis of thyroid and adrenal disorders. For more information, visit www.zomedica.com.